Navigation Links
Top Ten Pharma Company Deploys MedNet Solutions' Investigator Initiated Trial Management System

MINNETONKA, Minn., March 19 /PRNewswire/ -- MedNet Solutions, a global life sciences technology solutions company specializing in clinical study management systems, today announced that one of the world's largest pharmaceutical companies has deployed MedNet's Investigator Initiated Trial (IIT) Management System. This system provides a powerful, flexible and efficient solution to manage the entire IIT lifecycle... from proposal to publication... helping to ensure comprehensive, standardized and auditable IIT submissions, decisions and tracking on a world-wide basis.

"We are extremely pleased that MedNet has been selected to deliver the vital technology infrastructure required to fully automate, centralize and streamline the international IIT management processes of this industry leading pharmaceutical organization," stated John M. (Rob) Robertson, President and CEO of MedNet Solutions. "We believe this selection validates MedNet's continued commitment to providing the high level of expertise, technology and support needed to help life sciences organizations achieve operational efficiencies in all aspects of clinical research."

The MedNet IIT Management System delivers robust, highly configurable capabilities that allow pharmaceutical, medical device and biotechnology companies to achieve global IIT management standardization, increased IIT visibility, and reduced IIT program related time and cost expenditures. The solution also delivers the tools needed to shorten timelines from concept submission to publication, minimize redundant studies, and enhance investigator and management satisfaction.

About MedNet Solutions

MedNet Solutions is a leading healthcare technology company specializing in clinical study management systems designed for the global life sciences market. Applying critical insight, proven technology, and unwavering support, MedNet delivers powerful, flexible and easy-to-use web-based solutions that support our customers' clinical studies, registries and investigator initiated trials. Since 2000, MedNet has successfully supported leading pharmaceutical, medical device, and biotechnology organizations on projects spanning 6 continents and more than 40 countries. MedNet delivers a superior customer experience from beginning to end. For more information, please visit

    Contact Information:
    Dirk H. Nelson
    Marketing Manager
    601 Carlson Parkway, Suite 605
    Minnetonka, MN  55305
    (763) 258-2735

SOURCE MedNet Solutions
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. PharmAthene To Host Year-End 2008 Earnings Conference Call and Webcast on Monday, March 30, 2009
2. Frost & Sullivan Recognizes Novagali Pharma for Innovation in Ophthalmic Therapies
3. The Fitzsimons Redevelopment Authority Selects Pharmatech Oncology as Preferred Vendor
4. Maryland Business, Academic and Biopharma Groups Underscore Commitment to Medical Innovation, Finding Cures and Supporting the Economy
5. The Need for Safe and Affordable Biopharmaceuticals Drives the Development of the European Biosimilars Market, Says Frost & Sullivan
6. Quest PharmaTech Announces Strategic Alliance with IntelligentNano to Develop Nanotechnology-Based Next Generation SL052
7. Dr. Paul Korner Promoted to Senior Vice President of Ferring International PharmaScience Center U.S.
8. Tianyin Pharmaceutical Co., Inc. Adopts New Sales Strategy for Azithromycin Dispersible Tablets
9. PharmaNet Development Group Gives Notice of Anticipated Fundamental Change and Merger to Holders of Its Convertible Notes
10. Helix BioPharma Announces Q2 2009 Financial Results
11. RoundTable Healthcare Partners Facilitates Product Acquisition for CorePharma
Post Your Comments:
(Date:6/24/2016)... ... June 24, 2016 , ... Researchers at the Universita Politecnica delle Marche ... with peritoneal or pleural mesothelioma. Their findings are the subject of a new article ... Diagnostic biomarkers are signposts in the blood, lung fluid or tissue of mesothelioma patients ...
(Date:6/23/2016)... WI (PRWEB) , ... June 23, 2016 , ... ... supplements, is pleased to announce the launch of their brand, UP4™ Probiotics, into ... for over 35 years, is proud to add Target to its list of ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... , June 23, 2016 Houston ... with the Cy-Fair Sports Association to serve as ... the agreement, Houston Methodist Willowbrook will provide sponsorship ... and connectivity with association coaches, volunteers, athletes and ... with the Cy-Fair Sports Association and to bring ...
Breaking Biology Technology:
(Date:4/13/2016)... physicians supporting Medicaid patients in Central Florida ... telehealth thanks to a new partnership with higi.   ... can routinely track key health measurements, such as blood ... they opt in, share them with IMPOWER clinicians through ... location at no cost. By leveraging this data, IMPOWER ...
(Date:3/29/2016)... LegacyXChange, Inc. (OTC: LEGX ... Protect are pleased to announce our successful effort to ... of writing instruments, ensuring athletes signatures against counterfeiting and ... athletes on LegacyXChange will be assured of ongoing proof ... Bill Bollander , CEO states, "By inserting ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):